NIA's #1 Favorite DMT Play: ENBI

The psychedelic drug that NIA's President Gerard Adams has benefited the most from has been DMT as well as Ayahuasca a hallucinogenic beverage made from DMT. The insights learned by Gerard with the help of 5-MeO-DMT and Ayahuasca have allowed Gerard to grow spiritually and become much more successful as an entrepreneur.

There is only one publicly traded company that is well-positioned to capitalize on rapidly growing interest in DMT and Ayahuasca: Entheon Biomedical (CSE: ENBI), which also trades on the U.S. OTC under the symbol ENTBF.

ENBI is currently trading for $1.02 per share with 52,320,271 shares outstanding and a market cap of CAD$53.367 million.

We are excited to officially announce ENBI as our #1 favorite DMT stock suggestion and #2 favorite psychedelic stock suggestion for 2021!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from ENBI of USD$30,000 cash for a three-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.